
Personalized Treatment Strategies for Seborrheic Dermatitis
Dermatologists tailor seborrheic dermatitis care with shared decisions, steroid-sparing options, combo therapy, and flare-ready expectations.
Episodes in this series

In the final episode, Personalized Treatment Strategies for Seborrheic Dermatitis, the panelists explored the following critical questions:
How do patient characteristics and patient preferences influence treatment selection for patients with SD?
How does disease severity influence your approach to sequencing treatments over time and using combination therapy when managing SD?
How do you tailor patient counseling around tolerability and expectations when initiating therapy for SD across different patient populations?
Led by the Dr. Bunick, Dr. Ungar examines patient characteristics, including age, skin type, comorbidities, and previous treatment responses, which play a critical role in selecting appropriate therapy for seborrheic dermatitis (SD). Patient preferences, such as ease of use, vehicle type, and concern about potential side effects, also influence adherence and long-term outcomes. Disease severity guides the intensity and sequencing of treatment, with mild cases often managed with monotherapy, while moderate-to-severe or refractory cases may require combination approaches, such as pairing antifungals with anti-inflammatory agents. Sequencing treatments strategically over time can help control flares, prevent rebound, and minimize cumulative side effects, particularly with topical steroids. Counseling patients on tolerability, expected onset of efficacy, and potential adverse events is essential to set realistic expectations and promote adherence. This counseling should be tailored to different populations—for example, emphasizing gentle, non-irritating formulations for children or sensitive skin, and addressing cosmetic concerns in adults. Educating patients on proper application techniques and maintenance strategies can also improve outcomes. Overall, individualized treatment planning that considers patient characteristics, disease severity, and preferences supports more effective, sustainable management of SD.
Throughout the conversation, the experts provided a comprehensive reflection on the field and the factors that may shape how clinicians approach care moving forward.
Thank you for watching this DermView series on seborrheic dermatitis. Please subscribe to our newsletter for information on upcoming video series.













